At MFMac, we bring deep sectoral insight to support the innovation, growth and resilience of Scotland’s healthcare and life sciences ecosystem. Our cross-disciplinary legal team advises clients across the public and private sectors – from NHS Boards and biotech start-ups to care providers, med-tech innovators and private healthcare organisations.
At MFMac, we provide strategic legal guidance to healthcare and life sciences organisations operating in a complex and fast-evolving regulatory landscape. Our cross-disciplinary team supports clients from early-stage research through to commercialisation, helping them manage risk, ensure compliance and scale with confidence.
Our healthcare lawyers advise on regulatory matters, quality assurance and data governance and we structure R&D agreements including sponsorships, collaborations, MTAs and CDAs. Our expertise also covers clinical trial agreements, commercial contracts – such as licensing, distribution, consultancy, supply and manufacturing – and CRO arrangements. In addition, we help clients protect and maximise their intellectual property.
At MFMac, we help healthcare and life sciences businesses scale with confidence.
Our commercially focused legal support will help power your growth through all the phases and stages – whether that is around strategic structuring, supply chain management, attracting investment or planning expansion. From mergers and acquisitions to joint ventures and capital fundraising, we deliver pragmatic legal solutions that drive innovation, unlock investment and support ambition.
MFMac advises clients across the healthcare and life sciences sector (including care providers, bioTech, medtech, digital health and patient technologies and data and AI-driven life sciences) on commercial, regulatory and transactional matters. Our sector-focused team delivers practical legal solutions that support innovation and growth.
Digital health technologies are transforming elite sport, generating valuable performance and health data alongside complex legal considerations. This article explores how intellectual property, contract and data protection law interact and where key legal risks arise.
Scotland’s life sciences sector is entering a new growth phase, supported by increased public investment. Mergers and acquisitions can offer a faster route to scale in a sector shaped by long development timelines. Success, however, depends on early preparation, strong due diligence and clear strategic intent.
Rapid growth in non‑surgical cosmetic treatments has exposed safety risks due to inconsistent standards and training. New Scottish legislation introduces licensing and age restrictions for lower‑risk procedures, with plans to limit higher‑risk treatments to regulated healthcare settings from 2027.
This article reviews the CMA’s final report on the UK veterinary services market, outlining significant new regulatory requirements aimed at improving competition, price transparency and consumer choice. It explains the key remedies veterinary practices will need to comply with and considers the wider implications for other regulated service markets.
MFMac advises healthcare and life sciences clients on IP, IT, immigration and regulatory compliance – supporting innovation, protecting assets and navigating complex legal frameworks.
Our dedicated team of legal experts brings deep sector insight and proven experience to support healthcare and life sciences leaders in navigating complex regulations, protecting innovation and accelerating growth.